Fuji Pharma Co., Ltd. (FUP) Income Statement
0 Followers
Fuji Pharma Co., Ltd. Income Statement
Last quarter (Q3 2026), Fuji Pharma Co., Ltd.'s total revenue was ¥15.67B, an increase of 21.83% from the same quarter last year. In Q3, Fuji Pharma Co., Ltd.'s net income was ¥1.11B. See Fuji Pharma Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Sep 25 | Sep 24 | Sep 23 | Sep 22 | Sep 21 |
|---|---|---|---|---|---|
| ¥ 51.68B | ¥ 46.14B | ¥ 40.89B | ¥ 35.43B | ¥ 33.99B | |
| ¥ 19.29B | ¥ 16.51B | ¥ 15.37B | ¥ 13.62B | ¥ 14.13B | |
| ¥ 14.30B | ¥ 12.63B | ¥ 11.52B | ¥ 9.84B | ¥ 10.79B | |
| Depreciation and Amortization | ¥ 3.96B | ¥ 3.68B | ¥ 3.02B | ¥ 2.75B | ¥ 2.11B |
| ¥ 8.96B | ¥ 7.56B | ¥ 6.88B | ¥ 6.52B | ¥ 5.46B | |
| ¥ 4.99B | ¥ 3.88B | ¥ 3.86B | ¥ 3.78B | ¥ 3.35B | |
| ¥ -990.00M | ¥ 4.39B | ¥ 540.00M | ¥ -55.00M | ¥ 22.00M | |
| ¥ 4.00B | ¥ 8.28B | ¥ 4.40B | ¥ 3.72B | ¥ 3.37B | |
| ¥ 3.00B | ¥ 6.15B | ¥ 3.44B | ¥ 2.70B | ¥ 2.43B | |
| Per Share Metrics | |||||
| Basic EPS | ¥ 122.93 | ¥ 252.81 | ¥ 141.35 | ¥ 110.98 | ¥ 90.52 |
| Diluted EPS | ¥ 122.93 | ¥ 252.81 | ¥ 141.35 | ¥ 110.98 | ¥ 90.52 |
| Weighted Average Shares Outstanding | 24.40M | 24.31M | 24.30M | 24.29M | 26.87M |
| Weighted Average Shares Outstanding (Diluted) | 24.40M | 24.31M | 24.30M | 24.29M | 26.87M |
Currency in JPY
